Resolution of Visual Field Defect in Macroprolactinoma After Treatment With Cabergoline
We report the case of a 49-year-old woman presenting with amenorrhea and progressive visual field defect for one month. Endocrinological workup revealed a high concentration of serum prolactin, and magnetic resonance imaging (MRI) showed pituitary macroadenoma with extrasellar extension as well as c...
Gespeichert in:
| Veröffentlicht in: | Curēus (Palo Alto, CA) CA), 2022-05, Vol.14 (5) |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 5 |
| container_start_page | |
| container_title | Curēus (Palo Alto, CA) |
| container_volume | 14 |
| creator | Shibue, Kimitaka Yamakawa, Momoko Nishida, Namiko Hamasaki, Akihiro |
| description | We report the case of a 49-year-old woman presenting with amenorrhea and progressive visual field defect for one month. Endocrinological workup revealed a high concentration of serum prolactin, and magnetic resonance imaging (MRI) showed pituitary macroadenoma with extrasellar extension as well as compression of optic nerves. Treatment with a dopamine agonist, cabergoline, for eight weeks led to the resolution of the visual field defect accompanied by a rapid decrease in the serum prolactin level. Follow-up MRI three months after the initial diagnosis revealed alleviation of visible mechanical compression of the optic chiasm by the tumor. We considered that the absence of retinal nerve damage and prompt initiation of cabergoline contributed to the rapid recovery of the visual acuity. |
| doi_str_mv | 10.7759/cureus.25548 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9246700</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2696791796</sourcerecordid><originalsourceid>FETCH-LOGICAL-c243t-31c2b665b55bea4aef6bc7c6dd9ec3bdc2400196180b0c074a39108b67a5edfe3</originalsourceid><addsrcrecordid>eNpVkU9LAzEQxYMoVmpvfoCAV1uT_ZNkL0KpVoWKINUeQ5KdbVN2NzXJCn57V1tETzMwP9483kPogpIJ53lxbToPXZgkeZ6JI3SWUCbGgors-M8-QKMQtoQQSnhCODlFgzTnIhUiO0OrFwiu7qJ1LXYVfrOhUzWeW6hLfAsVmIhti5-U8W7nXa1MtK1rFJ5WETxeelCxgTbilY0bPFMa_NrVtoVzdFKpOsDoMIfodX63nD2MF8_3j7PpYmySLI3jlJpEM5brPNegMgUV04YbVpYFmFSXPdX7LhgVRBNDeKbSghKhGVc5lBWkQ3Sz1911uoHS9F68quXO20b5T-mUlf8vrd3ItfuQRZIxTkgvcHkQ8O69gxDl1nW-7T3LhBWMF5QXrKeu9lSfQwgeqt8PlMjvJuS-CfnTRPoFARR9kw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2696791796</pqid></control><display><type>article</type><title>Resolution of Visual Field Defect in Macroprolactinoma After Treatment With Cabergoline</title><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Shibue, Kimitaka ; Yamakawa, Momoko ; Nishida, Namiko ; Hamasaki, Akihiro</creator><creatorcontrib>Shibue, Kimitaka ; Yamakawa, Momoko ; Nishida, Namiko ; Hamasaki, Akihiro</creatorcontrib><description>We report the case of a 49-year-old woman presenting with amenorrhea and progressive visual field defect for one month. Endocrinological workup revealed a high concentration of serum prolactin, and magnetic resonance imaging (MRI) showed pituitary macroadenoma with extrasellar extension as well as compression of optic nerves. Treatment with a dopamine agonist, cabergoline, for eight weeks led to the resolution of the visual field defect accompanied by a rapid decrease in the serum prolactin level. Follow-up MRI three months after the initial diagnosis revealed alleviation of visible mechanical compression of the optic chiasm by the tumor. We considered that the absence of retinal nerve damage and prompt initiation of cabergoline contributed to the rapid recovery of the visual acuity.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.25548</identifier><identifier>PMID: 35783884</identifier><language>eng</language><publisher>Palo Alto: Cureus Inc</publisher><subject>Amenorrhea ; Case reports ; Defects ; Dopamine ; Endocrinology/Diabetes/Metabolism ; Magnetic resonance imaging ; Medical prognosis ; Medical research ; Neurosurgery ; Ophthalmology ; Optics ; Patients ; Pituitary gland ; Research centers ; Tumors</subject><ispartof>Curēus (Palo Alto, CA), 2022-05, Vol.14 (5)</ispartof><rights>Copyright © 2022, Shibue et al. This work is published under https://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2022, Shibue et al. 2022 Shibue et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c243t-31c2b665b55bea4aef6bc7c6dd9ec3bdc2400196180b0c074a39108b67a5edfe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246700/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246700/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Shibue, Kimitaka</creatorcontrib><creatorcontrib>Yamakawa, Momoko</creatorcontrib><creatorcontrib>Nishida, Namiko</creatorcontrib><creatorcontrib>Hamasaki, Akihiro</creatorcontrib><title>Resolution of Visual Field Defect in Macroprolactinoma After Treatment With Cabergoline</title><title>Curēus (Palo Alto, CA)</title><description>We report the case of a 49-year-old woman presenting with amenorrhea and progressive visual field defect for one month. Endocrinological workup revealed a high concentration of serum prolactin, and magnetic resonance imaging (MRI) showed pituitary macroadenoma with extrasellar extension as well as compression of optic nerves. Treatment with a dopamine agonist, cabergoline, for eight weeks led to the resolution of the visual field defect accompanied by a rapid decrease in the serum prolactin level. Follow-up MRI three months after the initial diagnosis revealed alleviation of visible mechanical compression of the optic chiasm by the tumor. We considered that the absence of retinal nerve damage and prompt initiation of cabergoline contributed to the rapid recovery of the visual acuity.</description><subject>Amenorrhea</subject><subject>Case reports</subject><subject>Defects</subject><subject>Dopamine</subject><subject>Endocrinology/Diabetes/Metabolism</subject><subject>Magnetic resonance imaging</subject><subject>Medical prognosis</subject><subject>Medical research</subject><subject>Neurosurgery</subject><subject>Ophthalmology</subject><subject>Optics</subject><subject>Patients</subject><subject>Pituitary gland</subject><subject>Research centers</subject><subject>Tumors</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpVkU9LAzEQxYMoVmpvfoCAV1uT_ZNkL0KpVoWKINUeQ5KdbVN2NzXJCn57V1tETzMwP9483kPogpIJ53lxbToPXZgkeZ6JI3SWUCbGgors-M8-QKMQtoQQSnhCODlFgzTnIhUiO0OrFwiu7qJ1LXYVfrOhUzWeW6hLfAsVmIhti5-U8W7nXa1MtK1rFJ5WETxeelCxgTbilY0bPFMa_NrVtoVzdFKpOsDoMIfodX63nD2MF8_3j7PpYmySLI3jlJpEM5brPNegMgUV04YbVpYFmFSXPdX7LhgVRBNDeKbSghKhGVc5lBWkQ3Sz1911uoHS9F68quXO20b5T-mUlf8vrd3ItfuQRZIxTkgvcHkQ8O69gxDl1nW-7T3LhBWMF5QXrKeu9lSfQwgeqt8PlMjvJuS-CfnTRPoFARR9kw</recordid><startdate>20220531</startdate><enddate>20220531</enddate><creator>Shibue, Kimitaka</creator><creator>Yamakawa, Momoko</creator><creator>Nishida, Namiko</creator><creator>Hamasaki, Akihiro</creator><general>Cureus Inc</general><general>Cureus</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20220531</creationdate><title>Resolution of Visual Field Defect in Macroprolactinoma After Treatment With Cabergoline</title><author>Shibue, Kimitaka ; Yamakawa, Momoko ; Nishida, Namiko ; Hamasaki, Akihiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c243t-31c2b665b55bea4aef6bc7c6dd9ec3bdc2400196180b0c074a39108b67a5edfe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Amenorrhea</topic><topic>Case reports</topic><topic>Defects</topic><topic>Dopamine</topic><topic>Endocrinology/Diabetes/Metabolism</topic><topic>Magnetic resonance imaging</topic><topic>Medical prognosis</topic><topic>Medical research</topic><topic>Neurosurgery</topic><topic>Ophthalmology</topic><topic>Optics</topic><topic>Patients</topic><topic>Pituitary gland</topic><topic>Research centers</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shibue, Kimitaka</creatorcontrib><creatorcontrib>Yamakawa, Momoko</creatorcontrib><creatorcontrib>Nishida, Namiko</creatorcontrib><creatorcontrib>Hamasaki, Akihiro</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shibue, Kimitaka</au><au>Yamakawa, Momoko</au><au>Nishida, Namiko</au><au>Hamasaki, Akihiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Resolution of Visual Field Defect in Macroprolactinoma After Treatment With Cabergoline</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><date>2022-05-31</date><risdate>2022</risdate><volume>14</volume><issue>5</issue><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>We report the case of a 49-year-old woman presenting with amenorrhea and progressive visual field defect for one month. Endocrinological workup revealed a high concentration of serum prolactin, and magnetic resonance imaging (MRI) showed pituitary macroadenoma with extrasellar extension as well as compression of optic nerves. Treatment with a dopamine agonist, cabergoline, for eight weeks led to the resolution of the visual field defect accompanied by a rapid decrease in the serum prolactin level. Follow-up MRI three months after the initial diagnosis revealed alleviation of visible mechanical compression of the optic chiasm by the tumor. We considered that the absence of retinal nerve damage and prompt initiation of cabergoline contributed to the rapid recovery of the visual acuity.</abstract><cop>Palo Alto</cop><pub>Cureus Inc</pub><pmid>35783884</pmid><doi>10.7759/cureus.25548</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2168-8184 |
| ispartof | Curēus (Palo Alto, CA), 2022-05, Vol.14 (5) |
| issn | 2168-8184 2168-8184 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9246700 |
| source | PubMed Central; PubMed Central Open Access |
| subjects | Amenorrhea Case reports Defects Dopamine Endocrinology/Diabetes/Metabolism Magnetic resonance imaging Medical prognosis Medical research Neurosurgery Ophthalmology Optics Patients Pituitary gland Research centers Tumors |
| title | Resolution of Visual Field Defect in Macroprolactinoma After Treatment With Cabergoline |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T16%3A50%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Resolution%20of%20Visual%20Field%20Defect%20in%20Macroprolactinoma%20After%20Treatment%20With%20Cabergoline&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Shibue,%20Kimitaka&rft.date=2022-05-31&rft.volume=14&rft.issue=5&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.25548&rft_dat=%3Cproquest_pubme%3E2696791796%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2696791796&rft_id=info:pmid/35783884&rfr_iscdi=true |